Lu Wu

No ORCID on file · 3 papers in corpus · active 2021-2026

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
  • adenomyosis 1
other 2026
Reduced type 2 epithelial-mesenchymal transition serves as a risk factor for the progression from endometriosis to endometriosis-associated ovarian cancer
Scientific reports ·doi:10.1038/s41598-026-51155-0

Endometriosis-associated ovarian cancer (EAOC) is a rare subtype of ovarian cancer arising from the malignant transformation of endometriosis (EMS). Despite growing clinical awareness, its underlying pathogenic mechanisms are not fully unde…

article 2023
Overexpression of lncRNA-MEG3 inhibits endometrial cell proliferation and invasion via miR-21-5p/DNMT3B/Twist
Clinics (Sao Paulo, Brazil) ·doi:10.1016/j.clinsp.2023.100235

Recent studies have found that lncRNA-MEG3(MEG3) plays an important role in the development of EMs (Endometriosis), but the specific mechanism needs to be further explored. This study aimed to investigate the effect of MEG3 on the prolifera…

article 2021
Hemoperitoneum caused by bleeding of adenomyosis: a case report
·doi:10.31083/j.ceog.2021.02.2119

Rationale: Adenomyosis is a disease in which the endometrial tissues (glands and stroma) extend into the myometrium. It usually occurs in parous women aged 35 to 50 years old. The common symptoms include secondary severe dysmenorrhea and me…